The independent source for health policy research, polling, and news.
6,301-6,320 of 112,946 results
News outlets reported a string of overseas deaths linked to drugs manufactured in India since 2022, and now Indian pharmaceutical firms have to meet new manufacturing standards just set by the government. Meanwhile, GSK is replacing Flovent brand asthma inhalers with an authorized generic.
New data from the CDC show that respiratory viruses soared during the holiday period. Thirty-eight states have high or very high infection rates. And although variant JN.1 is now dominating new covid infections, the CDC says flu is rising more dramatically than covid.
The Supreme Court will hear the case over Idaho's abortion law that bans the procedure even for certain medical emergency situations. In the meantime, the court will allow the measure to be enforced.
With a Jan. 19 deadline looming when funding for many federal programs would expire, congressional negotiators announced a $1.7 trillion agreement. If passed in time, the deal would preserve money for veterans assistance, food and drug safety services, and other health programs, while canceling unspent pandemic aid.
Today's early morning highlights from the major news organizations.
Editorial writers delve into insurance company denials, the ACA and more.
Each week, KFF Health News finds longer stories for you to enjoy. This week's selections include stories on abortion, anorexia, aspirin, birth policy in China, and more.
The state bill would ban doctors from providing gender-affirming surgery for minors and from referring patients to out-of-state alternatives. Also in the news: wheelchair repair legislation passed in Massachusetts; warnings of Shigella among the homeless in Portland, Oregon; and more.
The Research, Abuse, Diversion, and Addiction-Related Surveillance system was an in-house system at Purdue Pharma and later sold to the Denver Health and Hospital Authority. Advocacy groups are pushing back against the FDA's use of RADARS over its ties to the pharma industry.
Researchers used home security systems, including baby monitor video, as part of a study into unexplained toddler deaths. They found a link between seizures and sudden death. Meanwhile, another study shows how prevalent microplastics are in our food despite health risks.
The 1.7-mile-long bridge now has a continuous physical barrier as part of an effort to reduce suicide attempts made from the iconic structure. Meanwhile, in Texas, a $50 million mental health treatment center is approved, and Houston schools brace for the loss of covid mental health funding.
Axios reports that Elevance Health has struck a $1 billion deal to by Paragon Healthcare, a company that specializes in infusible and injectable therapies. Other health industry news reports on lawsuits, ambulance workers, hacking, and more.
The now-rejected legislation would have permanently continued coverage for nearly 57,000 low-income residents. Meanwhile, in Maryland, Medicaid expansions have now included more gender-affirming care options. A glimmer of hope is also seen for Medicaid expansion in Georgia.
Instead, a new large study finds a lower risk of new and recurrent suicidal thoughts in patients taking semaglutide, the active ingredient in popular weight-loss drugs Wegovy and Ozempic. News outlets also report on the drugs' impact on the insurance and pharmaceutical landscape.
The shooting occurred Thursday at a Perry, Iowa, high school. The 17-year-old shooter, Dylan Butler, was armed with two firearms. Butler's motives are reportedly unknown at this point, but social media debate has arisen over the possibility that he was bullied.
A new analysis attributes the excess deaths in six countries to the anti-malarial drug, with 12,000 of those deaths in the U.S. At that time in the covid pandemic, then-President Donald Trump said of the unproven treatment: "What do you have to lose? Take it."
It's a major policy shift and overrides fierce objections from the pharmaceutical industry, The New York Times reported. In other news, Axios reports that, ironically, generic drug shortages across the country are partly being driven by prices that may be too low.
Today's early morning highlights from the major news organizations.
Editorial writers weigh in on these topics and others.
Each week, KFF Health News compiles a selection of health policy studies and briefs.
© 2026 KFF